Boston.com US
BOSTON — In a windowless conference room at the Harvard T.H. Chan School of Public Health last Thursday, Amanda Spickard, an associate dean, sat with half a dozen colleagues, improvising a plan for the havoc about to unfold.
Within a few hours, more than 130 researchers at the graduate school would receive emails canceling the federal funding for their work. No other division of the university relies as heavily on government support, and Spickard’s team was all too aware that the loss of tens of millions of dollars would end careers, halt progress toward medical breakthroughs and reshape the institution.
As recently as a few weeks ago, everyone at the table had been consumed with other tasks in the Office of Research Strategy and Development, smoothing wrinkles with lab equipment or scie
New York Post
Axios